This indicator provides the rate of claims accepted by public drug programs for generic drugs.
This indicator is interpreted as the proportion of public drug program spending for generic drug products.
Data availability:
to (calendar years)
Geographic coverage
Newfoundland and Labrador, Prince Edward Island, New Brunswick, Nova Scotia, Quebec, Ontario, Manitoba, Saskatchewan, Alberta, British Columbia, Yukon
Reporting level
Province/Territory
Calculation
Total public drug program spending on generic drugs divided by total public drug program spending
Unit of Analysis: Spending from public drug programs
Denominator
Total public drug program spending
Numerator
Total public drug program spending on generic drug products
Comments
Not applicable